February 2025 in “The Indian Journal of Pediatrics” Siddha therapeutics successfully treated a 14-year-old's alopecia areata, leading to full hair regrowth without side effects.
1 citations
,
March 2025 in “Journal of Drug Delivery and Therapeutics” This review found that Seenthil Chooranam, a traditional Siddha formulation, has potential therapeutic benefits for various diseases due to its pharmacological properties and bioactive compounds, though further research is needed to confirm its safety and clinical effectiveness.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review compiles existing knowledge on the traditional uses, phytochemistry, and pharmacological activities of Eclipta alba, a plant with potential health benefits traditionally used in Ayurveda and other healing systems, encouraging further exploration of its therapeutic potential.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review compiles existing knowledge on the botanical characteristics, traditional uses, phytochemistry, and pharmacological activities of Eclipta alba, highlighting its potential therapeutic properties and encouraging further pharmacological and phytochemical exploration of this traditionally used medicinal plant.
October 2023 in “International journal of research in Ayurveda and pharmacy” This review found that the ingredients of Keedari thailam, a traditional Siddha formulation used for alopecia areata, exhibit antimicrobial, anti-inflammatory, and other pharmacological activities, suggesting potential therapeutic benefits according to recent research and Siddha literature.